VENUS CONCEPT INC (VERO) Stock Price, Quote, News and Overview
NASDAQ:VERO - Nasdaq - US92332W3034 - Common Stock - Currency: USD
VERO Quote, Performance and Key Statistics
NASDAQ:VERO (5/29/2025, 4:00:20 PM)
2.33
+0.04 (+1.75%)
The current stock price of VERO is 2.33 USD. In the past month the price decreased by -5.95%. In the past year, price decreased by -60.72%.
VERO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.79 | 231.14B | ||
| ISRG | INTUITIVE SURGICAL INC | 72.74 | 199.19B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.7 | 154.60B | ||
| SYK | STRYKER CORP | 30.51 | 146.12B | ||
| MDT | MEDTRONIC PLC | 14.98 | 105.69B | ||
| BDX | BECTON DICKINSON AND CO | 12.34 | 49.82B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.9 | 45.60B | ||
| IDXX | IDEXX LABORATORIES INC | 45.22 | 41.78B | ||
| RMD | RESMED INC | 27 | 35.94B | ||
| DXCM | DEXCOM INC | 51.43 | 33.27B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.55 | 32.75B | ||
| STE | STERIS PLC | 26.23 | 24.07B |
Related stock screener links
About VERO
Company Profile
Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Company Info
VENUS CONCEPT INC
235 Yorkland Blvd Suite 900
TORONTO ONTARIO M2J 4Y8 CA
CEO: Domenic Serafino
Employees: 292
Phone: 18778488430
VENUS CONCEPT INC / VERO FAQ
What is the stock price of VENUS CONCEPT INC today?
The current stock price of VERO is 2.33 USD. The price increased by 1.75% in the last trading session.
What is the ticker symbol for VENUS CONCEPT INC stock?
The exchange symbol of VENUS CONCEPT INC is VERO and it is listed on the Nasdaq exchange.
On which exchange is VERO stock listed?
VERO stock is listed on the Nasdaq exchange.
What is VENUS CONCEPT INC worth?
VENUS CONCEPT INC (VERO) has a market capitalization of 3.31M USD. This makes VERO a Nano Cap stock.
How many employees does VENUS CONCEPT INC have?
VENUS CONCEPT INC (VERO) currently has 292 employees.
What are the support and resistance levels for VENUS CONCEPT INC (VERO) stock?
VENUS CONCEPT INC (VERO) has a support level at 2.19 and a resistance level at 2.39. Check the full technical report for a detailed analysis of VERO support and resistance levels.
Is VENUS CONCEPT INC (VERO) expected to grow?
The Revenue of VENUS CONCEPT INC (VERO) is expected to decline by -8.02% in the next year. Check the estimates tab for more information on the VERO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VENUS CONCEPT INC (VERO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VERO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VERO, evaluating the profitability, health, valuation and growth aspects
- VENUS CONCEPT INC (VERO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VENUS CONCEPT INC (VERO) Sales and EPS estimates to see what analysts future expectations are.
- VENUS CONCEPT INC (VERO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VENUS CONCEPT INC (VERO) Insider and Institutional Ownership to learn about the owners and their transactions.
- VENUS CONCEPT INC (VERO) Stock Chart to make your own analysis
- VENUS CONCEPT INC (VERO) Latest news and press-releases to stay up to date.
Does VENUS CONCEPT INC (VERO) stock pay dividends?
VERO does not pay a dividend.
When does VENUS CONCEPT INC (VERO) report earnings?
VENUS CONCEPT INC (VERO) will report earnings on 2025-08-11, before the market open.
What is the Price/Earnings (PE) ratio of VENUS CONCEPT INC (VERO)?
VENUS CONCEPT INC (VERO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-76.3).
What is the Short Interest ratio of VENUS CONCEPT INC (VERO) stock?
The outstanding short interest for VENUS CONCEPT INC (VERO) is 2.97% of its float. Check the ownership tab for more information on the VERO short interest.
VERO Technical Analysis
VERO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VERO. VERO may be in some trouble as it scores bad on both profitability and health.
VERO Financial Highlights
Over the last trailing twelve months VERO reported a non-GAAP Earnings per Share(EPS) of -76.3. The EPS decreased by -3.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -78.1% | ||
| ROE | -2191.2% | ||
| Debt/Equity | 9.53 |
VERO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to VERO. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 55.64% and a revenue growth -8.02% for VERO